Siemens Medical DCA Vantage Analyzer JS Medical Equipment

Dca Vantage Analyzer. The DCA Vantage Analyzer for POC testing in a primary care facility Siemens Healthineers DCA Vantage™ Analyzer Provides precise and accurate quantitative test results for HbA1c in whole blood during the patient visit to help improve decision making DCA Vantage Analyzer is a semi-automated, bench top system

The DCA Vantage Analyzer helps you monitor glycemic control and detect early kidney disease in environments ranging from the physician's office to remote, point­of­care coordinated sites in hospitals and multisite practices Improved clinical confidence • Proven to provide accurate and precise lab-quality results • Barcode.

Dca Vantage Analyzer « Medical Mart

The DCA Vantage® Analyzer helps you monitor glycemic control and detect early kidney disease in environments ranging from the physician's office to remote, point-of-care coordinated sites in hospitals and multisite practices The DCA Vantage Analyzer is a point-of-care analyzer for diabetes management For tests, both the control kit and the test kit are needed

Siemens DCA Vantage Analyzer Creatinine Microalbumin Hba1c. The DCA Vantage Analyzer is the diabetes system that delivers clinically proven, clinically relevant HbA1c and A:C Ratio results shown to improve patient complianceOnly 1uL of whole blood needed for HbA1c testingHbA1c results in 6 minutesMicroalbumin testing allows for early detection of kidney disease - results available in 7 minutesPrinted patient records and electronic transmission to LIS. DCA Vantage Analyzer helps you better manage diabetes patients by providing quick results to enable actionable physician-patient conversations at the time of the visit

DCA Vantage® Analyzer Siemens Healthineers. The new DCA Vantage Analyser is the point of care diabetes system that gives you the most proven, clinically relevant menu available today, delivering enhanced HbA1C and Microalbumin testing results including A:C Ratio. The DCA Vantage ® Analyzer helps you monitor glycemic control and detect early kidney disease in environments ranging from the physician's office to remote, point-of-care coordinated sites in hospitals and multisite practices